ATE259817T1 - Herstellung von einem clavulansäuresalz - Google Patents
Herstellung von einem clavulansäuresalzInfo
- Publication number
- ATE259817T1 ATE259817T1 AT96939048T AT96939048T ATE259817T1 AT E259817 T1 ATE259817 T1 AT E259817T1 AT 96939048 T AT96939048 T AT 96939048T AT 96939048 T AT96939048 T AT 96939048T AT E259817 T1 ATE259817 T1 AT E259817T1
- Authority
- AT
- Austria
- Prior art keywords
- clavulanic acid
- pct
- butanol
- production
- date
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D503/02—Preparation
- C07D503/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
- C07D503/08—Modification of a carboxyl group directly attached in position 2, e.g. esterification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0186795A AT403375B (de) | 1995-11-15 | 1995-11-15 | Verfahren zur fällung von alkalisalzen der clavulansäure |
PCT/EP1996/005015 WO1997018216A1 (en) | 1995-11-15 | 1996-11-14 | Production of a salt of clavulanic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE259817T1 true ATE259817T1 (de) | 2004-03-15 |
Family
ID=3522721
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0186795A AT403375B (de) | 1995-11-15 | 1995-11-15 | Verfahren zur fällung von alkalisalzen der clavulansäure |
AT96939048T ATE259817T1 (de) | 1995-11-15 | 1996-11-14 | Herstellung von einem clavulansäuresalz |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0186795A AT403375B (de) | 1995-11-15 | 1995-11-15 | Verfahren zur fällung von alkalisalzen der clavulansäure |
Country Status (25)
Country | Link |
---|---|
US (1) | US6133441A (de) |
EP (1) | EP0874855B1 (de) |
JP (1) | JP4319252B2 (de) |
KR (1) | KR100537732B1 (de) |
CN (1) | CN1090636C (de) |
AT (2) | AT403375B (de) |
AU (1) | AU714017B2 (de) |
BR (1) | BR9611572A (de) |
CA (1) | CA2237763C (de) |
CZ (1) | CZ296567B6 (de) |
DE (1) | DE69631608T2 (de) |
ES (1) | ES2216073T3 (de) |
HK (1) | HK1016971A1 (de) |
HU (1) | HUP9903478A3 (de) |
IL (1) | IL124353A (de) |
MX (1) | MX9803887A (de) |
NO (1) | NO982107D0 (de) |
NZ (1) | NZ322485A (de) |
PL (1) | PL188634B1 (de) |
RU (1) | RU2179171C2 (de) |
SI (1) | SI0874855T1 (de) |
SK (1) | SK285138B6 (de) |
TR (1) | TR199800860T2 (de) |
TW (1) | TW427991B (de) |
WO (1) | WO1997018216A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI9400107A (en) * | 1994-03-02 | 1995-10-31 | Lek Tovarna Farmacevtskih | New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804. |
GB0003305D0 (en) | 2000-02-15 | 2000-04-05 | Zeneca Ltd | Pyrimidine derivatives |
DE60108154T2 (de) * | 2000-10-20 | 2005-12-22 | Sandoz Ag | Pharmazeutische Zubereitungen enthaltend Clavulansäure |
US8883772B2 (en) * | 2007-10-09 | 2014-11-11 | Sopharmia, Inc. | Broad spectrum beta-lactamase inhibitors |
WO2010118361A1 (en) * | 2009-04-09 | 2010-10-14 | Sopharmia, Inc. | Beta lactamase inhibitors |
DK2968352T3 (da) | 2013-03-12 | 2019-01-02 | Gladius Pharmaceuticals Corp | Derivatiserede 3-styryl-cephalosporiner |
CN109535184B (zh) * | 2017-09-21 | 2020-11-20 | 联邦制药(内蒙古)有限公司 | 一种克拉维酸叔辛胺制备克拉维酸钾的方法 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4110165A (en) * | 1974-04-20 | 1978-08-29 | Beecham Group Limited | Process for the production of clavulanic acid |
NZ177159A (en) * | 1974-04-20 | 1978-03-06 | Beecham Group Ltd | Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions |
US4144242A (en) * | 1975-02-07 | 1979-03-13 | Glaxo Laboratories Limited | Process for the purification of clavulanic acid |
GB2003863B (en) * | 1977-09-01 | 1982-03-31 | Beecham Group Ltd | Chemical process |
JO984B1 (en) * | 1977-10-11 | 1979-12-01 | بيتشام غروب ليمتد | A dry pharmaceutical compound with a suitable dosage unit for oral administration |
AU600655B2 (en) * | 1984-10-27 | 1990-08-23 | Beecham Group Plc | Preparation of clavulanic acid and its salts and esters |
GB8618888D0 (en) * | 1986-08-01 | 1986-09-10 | Davy Mckee Ltd | Process |
DK175709B1 (da) * | 1987-01-29 | 2005-01-31 | Beecham Group Plc | Fremgangsmåde til fremstilling af kalium-clavulanat |
US5679789A (en) * | 1987-01-29 | 1997-10-21 | Beecham Group, P.L.C. | Pharmaceutical compositions comprising potassium clavulanate and methods of using them |
ES2010143A6 (es) * | 1989-03-01 | 1989-10-16 | Pharma Mar S A Pharmar | Un nuevo procedimiento de obtencion del acido z(2r,5r)-3-(2-hiadroxietiliden)-7- oxo-4-oxa-1-azabiciclo(3,2,0) -heptano-2-carboxilico y de sales estares farmaceutiacamente aceptables del mismo,a partir de caldos de fermentacion de streptomyces, sp. |
US5210296A (en) * | 1990-11-19 | 1993-05-11 | E. I. Du Pont De Nemours And Company | Recovery of lactate esters and lactic acid from fermentation broth |
AT400033B (de) * | 1992-03-10 | 1995-09-25 | Biochemie Gmbh | Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben |
AT399155B (de) * | 1992-03-26 | 1995-03-27 | Lek Tovarna Farmacevtskih | Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung |
SI9300296B (sl) * | 1992-06-11 | 1998-06-30 | Smithkline Beecham P.L.C. | Postopek in intermedianti za pripravo klavulanske kisline |
SI9200139A (en) * | 1992-07-08 | 1994-03-31 | Lek Tovarna Farmacevtskih | New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them |
KR100200239B1 (ko) * | 1992-10-21 | 1999-06-15 | 김충환 | 클라불란산 칼륨염의 제조방법 |
GB9401969D0 (en) * | 1994-02-02 | 1994-03-30 | Smithkline Beecham Plc | Process |
SI9400107A (en) * | 1994-03-02 | 1995-10-31 | Lek Tovarna Farmacevtskih | New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804. |
TR199700828T1 (xx) * | 1995-02-25 | 1998-04-21 | Spurcourt Limited | .Klavulanik asit tuzlar�. |
GB2298201B (en) * | 1995-02-25 | 1997-05-28 | Spurcourt Ltd | Clavulanic acid salts |
SI9500074A (en) * | 1995-03-10 | 1996-10-31 | Lek Tovarna Farmacevtskih | Process for preparation of alkani salts of clavulanic acid. |
SI9500134B (sl) * | 1995-04-20 | 2004-04-30 | Lek, | Postopek za pripravo čistih alkalijskih soli klavulanske kisline |
KR100200242B1 (ko) * | 1995-05-16 | 1999-06-15 | 김충환 | 클라불란산염의 제조 방법 |
GB9515809D0 (en) * | 1995-08-02 | 1995-10-04 | Smithkline Beecham Plc | Process |
SI9500265A1 (en) * | 1995-08-28 | 1997-02-28 | Lek Tovarna Farmacevtskih | Process for purification of the aqueous fermented broth filtrate of streptomyces sp. p 6621 ferm p 2804 by ultrafiltration |
ZA975198B (en) * | 1996-06-13 | 1997-12-15 | Smithkline Beecham Corp | Improved process for preparing potassium clavulanate. |
CN1238776A (zh) * | 1996-11-11 | 1999-12-15 | 吉斯特-布罗卡迪斯有限公司 | 制备棒酸盐和酯的方法 |
-
1995
- 1995-11-15 AT AT0186795A patent/AT403375B/de not_active IP Right Cessation
-
1996
- 1996-11-14 DE DE69631608T patent/DE69631608T2/de not_active Expired - Lifetime
- 1996-11-14 BR BR9611572A patent/BR9611572A/pt not_active Application Discontinuation
- 1996-11-14 EP EP96939048A patent/EP0874855B1/de not_active Expired - Lifetime
- 1996-11-14 TR TR1998/00860T patent/TR199800860T2/xx unknown
- 1996-11-14 US US09/068,241 patent/US6133441A/en not_active Expired - Lifetime
- 1996-11-14 RU RU98111764/04A patent/RU2179171C2/ru not_active IP Right Cessation
- 1996-11-14 CA CA002237763A patent/CA2237763C/en not_active Expired - Fee Related
- 1996-11-14 TW TW085113953A patent/TW427991B/zh not_active IP Right Cessation
- 1996-11-14 WO PCT/EP1996/005015 patent/WO1997018216A1/en active IP Right Grant
- 1996-11-14 JP JP51859197A patent/JP4319252B2/ja not_active Expired - Fee Related
- 1996-11-14 HU HU9903478A patent/HUP9903478A3/hu unknown
- 1996-11-14 ES ES96939048T patent/ES2216073T3/es not_active Expired - Lifetime
- 1996-11-14 SI SI9630672T patent/SI0874855T1/xx unknown
- 1996-11-14 NZ NZ322485A patent/NZ322485A/xx unknown
- 1996-11-14 SK SK640-98A patent/SK285138B6/sk unknown
- 1996-11-14 IL IL12435396A patent/IL124353A/xx not_active IP Right Cessation
- 1996-11-14 KR KR1019980703498A patent/KR100537732B1/ko not_active IP Right Cessation
- 1996-11-14 AU AU76250/96A patent/AU714017B2/en not_active Ceased
- 1996-11-14 CZ CZ0149198A patent/CZ296567B6/cs not_active IP Right Cessation
- 1996-11-14 CN CN96199075A patent/CN1090636C/zh not_active Expired - Fee Related
- 1996-11-14 PL PL96326696A patent/PL188634B1/pl not_active IP Right Cessation
- 1996-11-14 AT AT96939048T patent/ATE259817T1/de active
-
1998
- 1998-05-08 NO NO982107A patent/NO982107D0/no not_active Application Discontinuation
- 1998-05-15 MX MX9803887A patent/MX9803887A/es unknown
-
1999
- 1999-04-26 HK HK99101818A patent/HK1016971A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE59402222D1 (de) | Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel | |
EA199800477A1 (ru) | Производные хинолина | |
ATE202337T1 (de) | Cyclopropylalkansäurederivate | |
ATE19870T1 (de) | 2-nitro-1,1-ethendiamine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel. | |
ATE259817T1 (de) | Herstellung von einem clavulansäuresalz | |
ATE132861T1 (de) | Derivate von hexahydroazepine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel | |
DE69628002D1 (de) | Herstellung von clavunalat-salzen | |
ATE36854T1 (de) | Tetrahydrothienopyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel. | |
ATE111734T1 (de) | Verfahren zur herstellung von direktkomprimierten, cephalosporansäure derivate enthaltendentabletten. | |
ATE21101T1 (de) | N-iminopyridinium-betain-derivate, ihre herstellung und ihre verwendung als arzneimittel. | |
MX9400165A (es) | Derivados de ter-butilergolina, proceso para su produccion y composiciones farmaceuticas que los contienen. | |
ATE37368T1 (de) | Benzothiazolon-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
CA2092919A1 (en) | Epoxysuccinamic acid derivatives | |
DE3269029D1 (en) | Bis-hydroxymethyl carbonate bridged antibacterial agents | |
DE58907390D1 (de) | Sulfonamide mit Tetrazolylrest, Verfahren zu ihrer Herstellung sowie Arzneimittel. | |
ATE7298T1 (de) | Basisch substituierte 5-phenyltetrazole, verfahren zu ihrer herstellung und ihre verwendung als heilmittel. | |
ATE80629T1 (de) | Beta-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als und in arzneimitteln. | |
DK0725785T3 (da) | Fremgangsmåde til fremstilling af rufloxacin af deraf | |
RU94046014A (ru) | Диаминовые соли клавулановой кислоты |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0874855 Country of ref document: EP |